{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:01:00Z","timestamp":1781632860254,"version":"3.54.5"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004772","name":"Natural Science Foundation of Ningxia Province","doi-asserted-by":"publisher","award":["No. 2022AAC03378"],"award-info":[{"award-number":["No. 2022AAC03378"]}],"id":[{"id":"10.13039\/501100004772","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To systematically investigate the prognostic value of DIAPH3 in prostate cancer (PCa) and explore its potential role in linking immunotherapy response and tumor microenvironment remodeling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed TCGA-PRAD, Stockholm, Moffitt, UK, and Yinchuan cohorts. DIAPH3 expression was compared between tumor and adjacent tissues. Kaplan\u2013Meier and multivariate Cox analyses were conducted to assess BCRFS and PFS. Immunotherapy response was analyzed using TIDE and IPS. Gene expression, somatic mutations, and immune microenvironment status were analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>High DIAPH3 expression correlates with poor prognosis and is an independent predictor of BCRFS, PFS, and RFS. Functional analyses show its involvement in cell cycle regulation and IL-17 signaling. Elevated DIAPH3 correlates with altered immune infiltration, including increased Th2 lymphocytes and decreased NK cells and pDCs. DIAPH3 expression associates with immunotherapy response, validated in a pan-cancer cohort. Drug sensitivity analysis revealed PI3K inhibitors are more effective in low DIAPH3 tumors, while PARP inhibitors are more effective in high DIAPH3 tumors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>DIAPH3 is a robust prognostic biomarker in PCa, linked to poor prognosis, immune infiltration, and therapeutic response. High DIAPH3 expression correlates with aggressive tumor progression and poor survival outcomes, highlighting its value for prognostic modeling and therapy selection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s12672-026-04413-6","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T17:34:44Z","timestamp":1768584884000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["DIAPH3 is a multifaceted prognostic biomarker that links immunotherapy response to tumor microenvironment in prostate cancer"],"prefix":"10.1007","volume":"17","author":[{"given":"Yuxuan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"issue":"3","key":"4413_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"4413_CR2","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1007\/s00259-015-3091-9","volume":"42","author":"P Mapelli","year":"2015","unstructured":"Mapelli P, Panebianco V, Picchio M. Prostate cancer recurrence: can PSA guide imaging? Eur J Nucl Med Mol Imaging. 2015;42(12):1781\u20133.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4413_CR3","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.14026.1","volume":"7","author":"A Afriansyah","year":"2018","unstructured":"Afriansyah A, Hamid A, Mochtar CA, et al. Prostate specific antigen (PSA) kinetic as a prognostic factor in metastatic prostate cancer receiving androgen deprivation therapy: systematic review and meta-analysis. F1000Res. 2018;7:246.","journal-title":"F1000Res"},{"issue":"4","key":"4413_CR4","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/aja.2008.36","volume":"11","author":"GW Lin","year":"2009","unstructured":"Lin GW, Yao XD, Zhang SL, et al. Prostate-specific antigen half-life: a new predictor of progression-free survival and overall survival in Chinese prostate cancer patients. Asian J Androl. 2009;11(4):443\u201350.","journal-title":"Asian J Androl"},{"issue":"5","key":"4413_CR5","first-page":"2418","volume":"25","author":"Q Wang","year":"2020","unstructured":"Wang Q, Ou T, Li J, et al. Research on the association of plasma TGF-beta1 level and blood lymphocyte\/monocyte ratio with pathological grade, clinical stage and prognosis of prostate cancer. J BUON. 2020;25(5):2418\u201323.","journal-title":"J BUON"},{"issue":"4","key":"4413_CR6","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/bem.10114","volume":"24","author":"MK Chung","year":"2003","unstructured":"Chung MK, Kim JC, Myung SH, et al. Developmental toxicity evaluation of ELF magnetic fields in Sprague-Dawley rats. Bioelectromagnetics. 2003;24(4):231\u201340.","journal-title":"Bioelectromagnetics"},{"issue":"1","key":"4413_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22677-0","volume":"12","author":"A Chen","year":"2021","unstructured":"Chen A, Ulloa Severino L, Panagiotou TC, et al. Inhibition of polar actin assembly by astral microtubules is required for cytokinesis. Nat Commun. 2021;12(1):2409.","journal-title":"Nat Commun"},{"issue":"12","key":"4413_CR8","doi-asserted-by":"publisher","first-page":"5004","DOI":"10.1091\/mbc.e05-10-0914","volume":"17","author":"CH Eng","year":"2006","unstructured":"Eng CH, Huckaba TM, Gundersen GG. The formin mDia regulates GSK3beta through novel PKCs to promote microtubule stabilization but not MTOC reorientation in migrating fibroblasts. Mol Biol Cell. 2006;17(12):5004\u201316.","journal-title":"Mol Biol Cell"},{"issue":"4","key":"4413_CR9","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1111\/jcmm.16196","volume":"25","author":"Y Rong","year":"2021","unstructured":"Rong Y, Gao J, Kuang T, et al. DIAPH3 promotes pancreatic cancer progression by activating selenoprotein TrxR1-mediated antioxidant effects. J Cell Mol Med. 2021;25(4):2163\u201375.","journal-title":"J Cell Mol Med"},{"issue":"23","key":"4413_CR10","doi-asserted-by":"publisher","first-page":"4688","DOI":"10.1002\/cam4.4793","volume":"11","author":"R Huang","year":"2022","unstructured":"Huang R, Wu C, Wen J, et al. DIAPH3 is a prognostic biomarker and inhibit colorectal cancer progression through maintaining EGFR degradation. Cancer Med. 2022;11(23):4688\u2013702.","journal-title":"Cancer Med"},{"key":"4413_CR11","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.biopha.2017.07.119","volume":"94","author":"J Jiang","year":"2017","unstructured":"Jiang J. Diaphanous-related formin-3 overexpression inhibits the migration and invasion of triple-negative breast cancer by inhibiting RhoA-GTP expression. Biomed Pharmacother. 2017;94:439\u201345.","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"4413_CR12","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/emmm.201200242","volume":"4","author":"MH Hager","year":"2012","unstructured":"Hager MH, Morley S, Bielenberg DR, et al. DIAPH3 governs the cellular transition to the amoeboid tumour phenotype. EMBO Mol Med. 2012;4(8):743\u201360.","journal-title":"EMBO Mol Med"},{"issue":"3","key":"4413_CR13","doi-asserted-by":"publisher","first-page":"689","DOI":"10.18632\/aging.204459","volume":"15","author":"X Chen","year":"2023","unstructured":"Chen X, Xie L, Qiao K, et al. The pan-cancer analysis identified DIAPH3 as a diagnostic biomarker of clinical cancer. Aging Albany NY. 2023;15(3):689\u2013704.","journal-title":"Aging Albany NY"},{"key":"4413_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.910950","volume":"9","author":"B Zhang","year":"2022","unstructured":"Zhang B, Hu Q, Li Y, et al. Diaphanous-related formin subfamily: novel prognostic biomarkers and tumor microenvironment regulators for pancreatic adenocarcinoma. Front Mol Biosci. 2022;9:910950.","journal-title":"Front Mol Biosci"},{"issue":"1","key":"4413_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00011-023-01817-w","volume":"73","author":"Y Fu","year":"2024","unstructured":"Fu Y, Zhang J, Liu Q, Yang L, Wu Q, Yang X, et al. Unveiling the role of ABI3 and hub senescence-related genes in macrophage senescence for atherosclerotic plaque progression. Inflamm Res. 2024;73(1):65\u201382.","journal-title":"Inflamm Res"},{"issue":"15","key":"4413_CR16","doi-asserted-by":"publisher","first-page":"1460308","DOI":"10.3389\/fimmu.2024.1460308","volume":"12","author":"L Wang","year":"2024","unstructured":"Wang L, Zhou X, Yan H, Miao Y, Wang B, Gu Y, et al. Deciphering the role of tryptophan metabolism-associated genes ECHS1 and ALDH2 in gastric cancer: implications for tumor immunity and personalized therapy. Front Immunol. 2024;12(15):1460308.","journal-title":"Front Immunol"},{"key":"4413_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.70018","volume":"5","author":"F Ma","year":"2025","unstructured":"Ma F, Wang L, Chi H, Li X, Xu Y, Chen K, et al. Exploring the therapeutic potential of MIR-140-3p in osteoarthritis: targeting cilp and ferroptosis for novel treatment strategies. Cell Prolif. 2025;5:e70018.","journal-title":"Cell Prolif"},{"issue":"1","key":"4413_CR18","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/s12885-025-13650-x","volume":"25","author":"P Zhang","year":"2025","unstructured":"Zhang P, Wang L, Liu H, Lin S, Guo D. Unveiling the crucial role of glycosylation modification in lung adenocarcinoma metastasis through artificial neural network-based spatial multi-omics single-cell analysis and Mendelian randomization. BMC Cancer. 2025;25(1):249.","journal-title":"BMC Cancer"},{"issue":"1","key":"4413_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/biof.2130","volume":"51","author":"J Tang","year":"2025","unstructured":"Tang J, Wei W, Xu Y, Chen K, Miao Y, Fan W, et al. CXC chemokine receptor 4-mediated immune modulation and tumor microenvironment heterogeneity in gastric cancer: utilizing multi\u2010omics approaches to identify potential therapeutic targets. BioFactors. 2025;51(1):e2130.","journal-title":"BioFactors"},{"issue":"1","key":"4413_CR20","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s12672-024-01322-4","volume":"15","author":"Q Xu","year":"2024","unstructured":"Xu Q, Liu C, Wang H, Li S, Yan H, Liu Z, et al. Deciphering the impact of aggregated autophagy-related genes TUBA1B and HSP90AA1 on colorectal cancer evolution: a single-cell sequencing study of the tumor microenvironment. Discov Oncol. 2024;15(1):431.","journal-title":"Discov Oncol."},{"issue":"1","key":"4413_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s12672-025-01760-8","volume":"16","author":"Y Chen","year":"2025","unstructured":"Chen Y, Yan H, Xu Y, Chen K, Yang R, Yang J, et al. Analysis of the predictive value of the prostate-specific antigen-to-neutrophil ratio for the diagnosis of prostate cancer. Discov Oncol. 2025;16(1):13.","journal-title":"Discov Oncol"},{"issue":"12","key":"4413_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18403","volume":"28","author":"H Chen","year":"2024","unstructured":"Chen H, Zuo H, Huang J, Liu J, Jiang L, Jiang C, et al. Unravelling infiltrating T-cell heterogeneity in kidney renal clear cell carcinoma: integrative single-cell and spatial transcriptomic profiling. J Cell Mol Med. 2024;28(12):e18403.","journal-title":"J Cell Mol Med"},{"issue":"2","key":"4413_CR23","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","volume":"173","author":"J Liu","year":"2018","unstructured":"Liu J, Lichtenberg T, Hoadley KA, Poisson LM, Lazar AJ, Cherniack AD, et al. An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell. 2018;173(2):400-416.e11.","journal-title":"Cell"},{"issue":"9","key":"4413_CR24","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.ebiom.2015.07.017","volume":"2","author":"H Ross-Adams","year":"2015","unstructured":"Ross-Adams H, Lamb AD, Dunning MJ, Halim S, Lindberg J, Massie CM, et al. Integration of copy number and transcriptomics provides risk stratification in prostate cancer: a discovery and validation cohort study. EBioMedicine. 2015;2(9):1133\u201344.","journal-title":"EBioMedicine"},{"key":"4413_CR25","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/4228241","volume":"2021","author":"L Wan","year":"2021","unstructured":"Wan L, Zhu J, Wu Q. Knockdown of DIAPH3 inhibits the proliferation of cervical cancer cells through inactivating mTOR signaling pathway. J Oncol. 2021;2021:4228241.","journal-title":"J Oncol"},{"issue":"1","key":"4413_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2019.111662","volume":"385","author":"G Xiang","year":"2019","unstructured":"Xiang G, Weiwei H, Erji G, et al. DIAPH3 promotes the tumorigenesis of lung adenocarcinoma. Exp Cell Res. 2019;385(1):111662.","journal-title":"Exp Cell Res"},{"issue":"1-2","key":"4413_CR27","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s11010-017-3125-7","volume":"438","author":"L Dong","year":"2018","unstructured":"Dong L, Li Z, Xue L, et al. DIAPH3 promoted the growth, migration and metastasis of hepatocellular carcinoma cells by activating beta-catenin\/TCF signaling. Mol Cell Biochem. 2018;438(1\u20132):183\u201390.","journal-title":"Mol Cell Biochem"},{"issue":"2","key":"4413_CR28","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S0094-0143(05)70386-4","volume":"24","author":"CR Pound","year":"1997","unstructured":"Pound CR, Partin AW, Epstein JI, et al. Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control. Urol Clin North Am. 1997;24(2):395\u2013406.","journal-title":"Urol Clin North Am"},{"issue":"1","key":"4413_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03398-4","volume":"20","author":"F Lyu","year":"2022","unstructured":"Lyu F, Li Y, Yan Z, et al. Identification of ISG15 and ZFP36 as novel hypoxia- and immune-related gene signatures contributing to a new perspective for the treatment of prostate cancer by bioinformatics and experimental verification. J Transl Med. 2022;20(1):202.","journal-title":"J Transl Med"},{"issue":"10","key":"4413_CR30","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1136\/ijgc-2020-001409","volume":"30","author":"J Wu","year":"2020","unstructured":"Wu J, Zhang H, Li L, et al. Prognostic nomogram for predicting survival in patients with high grade endometrial stromal sarcoma: a surveillance epidemiology, and end results database analysis. Int J Gynecol Cancer. 2020;30(10):1520\u20137.","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"4413_CR31","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1007\/s11255-023-03560-x","volume":"55","author":"Y Wang","year":"2023","unstructured":"Wang Y, Zhu Y, Fan L, et al. The prognostic nomogram for PSA-incongruent low-risk prostate cancer treated by radical prostatectomy. Int Urol Nephrol. 2023;55(6):1447\u201352.","journal-title":"Int Urol Nephrol"},{"key":"4413_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/srep12136","volume":"5","author":"S Morley","year":"2015","unstructured":"Morley S, You S, Pollan S, et al. Regulation of microtubule dynamics by DIAPH3 influences amoeboid tumor cell mechanics and sensitivity to taxanes. Sci Rep. 2015;5:12136.","journal-title":"Sci Rep"},{"issue":"5","key":"4413_CR33","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.ijrobp.2015.08.005","volume":"93","author":"M Roach","year":"2015","unstructured":"Roach M, Ceron Lizarraga TL, Lazar AA. Radical prostatectomy versus radiation and androgen deprivation therapy for clinically localized prostate cancer: how good is the evidence? Int J Radiat Oncol Biol Phys. 2015;93(5):1064\u201370.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4413_CR34","doi-asserted-by":"crossref","unstructured":"Tang C, Li A, Wei X. Comparison of prognosis after external beam radiotherapy versus radical prostatectomy in prostate cancer patients. Asian J Surg, 2024","DOI":"10.1016\/j.asjsur.2023.12.123"},{"issue":"1","key":"4413_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-6391-9","volume":"19","author":"X Rui","year":"2019","unstructured":"Rui X, Shao S, Wang L, et al. Identification of recurrence marker associated with immune infiltration in prostate cancer with radical resection and build prognostic nomogram. BMC Cancer. 2019;19(1):1179.","journal-title":"BMC Cancer"},{"issue":"Suppl","key":"4413_CR36","doi-asserted-by":"publisher","first-page":"S199","DOI":"10.1016\/j.semcancer.2015.02.007","volume":"35","author":"SC Casey","year":"2015","unstructured":"Casey SC, Amedei A, Aquilano K, et al. Cancer prevention and therapy through the modulation of the tumor microenvironment. Semin Cancer Biol. 2015;35(Suppl):S199\u2013223.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"4413_CR37","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.canlet.2015.12.022","volume":"380","author":"SL Shiao","year":"2016","unstructured":"Shiao SL, Chu GC, Chung LW. Regulation of prostate cancer progression by the tumor microenvironment. Cancer Lett. 2016;380(1):340\u20138.","journal-title":"Cancer Lett"},{"issue":"1","key":"4413_CR38","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s12672-024-01322-4","volume":"15","author":"Q Xu","year":"2024","unstructured":"Xu Q, Liu C, Wang H, Li S, Yan H, Liu Z, et al. Deciphering the impact of aggregated autophagy-related genes TUBA1B and HSP90AA1 on colorectal cancer evolution: a single-cell sequencing study of the tumor microenvironment. Discov Oncol. 2024;15(1):431.","journal-title":"Discov Oncol"},{"key":"4413_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.669474","volume":"12","author":"A Basu","year":"2021","unstructured":"Basu A, Ramamoorthi G, Albert G, et al. Differentiation and regulation of T(H) cells: a balancing act for cancer immunotherapy. Front Immunol. 2021;12:669474.","journal-title":"Front Immunol"},{"issue":"4","key":"4413_CR40","doi-asserted-by":"publisher","first-page":"409","DOI":"10.4161\/cbt.27627","volume":"15","author":"J Kim","year":"2014","unstructured":"Kim J, Morley S, Le M, et al. Enhanced shedding of extracellular vesicles from amoeboid prostate cancer cells: potential effects on the tumor microenvironment. Cancer Biol Ther. 2014;15(4):409\u201318.","journal-title":"Cancer Biol Ther"},{"issue":"8","key":"4413_CR41","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1002\/pros.23343","volume":"77","author":"Q Zhang","year":"2017","unstructured":"Zhang Q, Liu S, Ge D, et al. Targeting Th17-IL-17 pathway in prevention of micro-invasive prostate cancer in a mouse model. Prostate. 2017;77(8):888\u201399.","journal-title":"Prostate"},{"issue":"10","key":"4413_CR42","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1002\/pros.23990","volume":"80","author":"S Liu","year":"2020","unstructured":"Liu S, Liu F, Zhang B, et al. CD4(+) t helper 17 cell response of aged mice promotes prostate cancer cell migration and invasion. Prostate. 2020;80(10):764\u201376.","journal-title":"Prostate"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-04413-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04413-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04413-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:45:32Z","timestamp":1781631932000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-04413-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4413"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-04413-6","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"20 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods were carried out in accordance with protocols approved by Ethics Committee of Ningxia Hui Autonomous Region People\u2019s Hospital, and the study has applied for an ethical informed consent exemption (approved ID: [2021]-NZR-127).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"286"}}